Growing Trends in Reprocessed Medical Devices Market

The global reprocessed medical devices market is expected to be valued at US$2.58 bn by the end of 2020. The market was recorded at US$0.78 bn in 2013 and is shown to be progressing at a CAGR of 19.30% within a forecast period of 2014 to 2020. The statistical details are provided in a research report released by Transparency Market Research, titled “Reprocessed Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 -2020.” The report provides a clear description of this market in terms of growth prospects as well as inhibitors, along with a competitive landscape replete with the most recent data on the top players of the market.

According to the report, the primary factor driving the reprocessed medical devices market’s growth is the increasing demand for the employment of cost-saving measures in the medical devices industry. A large number of healthcare organizations are already pushing for higher levels of recycling and reprocessing medical devices in an attempt to save on medical costs and expenditures. At the same time, these bodies are also acting in response to the growing pressure exerted by governments regarding the amount of medical waste currently generated. There is a marked increase in the number of initiatives taken by government organizations in the field of waste management, and support for the global reprocessed medical devices market is one of them.

Other significant factors promoting the global reprocessed medical devices market include the advancements in technologies that allow a better quality of reprocessed devices. This driver is applicable especially to North America.

According to the Association of Medical Device Reprocessors, a standard hospital or healthcare organization in the world can manage to generate savings of at least US$500,000 and up to US$2 mn annually, with the help of reprocessed medical devices.

The report also signals users of the various restraints that might affect the market’s growth in the near future. Of these, the most prominent inhibitor is the significantly lower level of awareness of quality reprocessed medical devices. Another hindrance to the global reprocessed medical devices market is the negative perception of patients as well as medical organizations toward reprocessing.

In terms of devices, the global reprocessed medical devices market is largely propelled by the cardiovascular devices segment, which is showing the fastest growth rate among all device types, for the given forecast period. This segment owes its growth rate to a higher rate of use and the improving quality of cardiovascular reprocessed devices.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2064

North America dominated the global reprocessed medical devices market in 2013, due to early implementation of favorable policies and government incentives. Similar features can be seen in the European reprocessed medical devices market. Both developed regions are facing major constraints due to the rapidly increasing cost of administering medical attention.

The key players in the reprocessed medical devices market are ReNu Medical, Inc., Centurion Medical Products Corp., Hygia Health Services, Inc., MidWest Reprocessing Center, SterilMed, Inc., Medline ReNewal, SureTek Medical, Stryker Sustainability, and Vanguard AG.

Microscopy Devices Market Offering High-growth Opportunities for Market Players

The growth of the global microscopy devices market is gaining momentum due to several reasons. Pioneered by the Dutch almost a millennium ago owing to their mastery in optical lenses, today, microscopes have evolved and diversified exponentially. Besides their use for academic and exploratory research, microscopes are finding utilization in newer areas of nanotechnology, atomic-scale semiconductor devices that require higher penetrative mediums such as electrons, and X-rays. Thus, the use of microscopes befits nanoscale-range observations, thereby boosting innovations in several areas of exploratory research.

Research-based Innovation Drives Demand for Microscopes in Industrial Applications

In the present times, it is the industrial segment that exhibits the largest demand for advanced microscopes, which is observed mainly in the microprocessor and integrated circuit manufacture industries. Besides their novel uses, optical microscopes have always been used in medical fields, schools and educational academies to introduce microscopic use to students at the elementary level. Due to the increasing proliferation of microscopes across several fields, newer equipment is being manufactured in creative designs and attractive colors for young individuals.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=226

In spite of the proliferation of microscopes in practically every field that requires research and testing, the microscopy devices market is displaying a slowed progression. The recently ended economic slump in Europe and in the Middle East are among the reasons for this. The premium pricing of advanced microscopes has limited their use in developing countries. The growth of the microscopy devices market is also hindered due to instrument-related complexities of advanced microscopic devices.

These factors will result in the microscopy devices market reaching a valuation of US$9.69 bn by 2020 increasing from US$5.75 bn in 2013 at a CAGR of 7.6% for the period.

Optical Microscopes Dominated Microscopy Devices Market in 2013

Product, application, and geography are the three criteria based on which the microscopy devices is divided. By product, electron microscopes, scanning probe microscopes, optical microscopes, and others are the segments of this market. Amongst these, optical microscopes accounted for a share of 38.9% in the global market in 2013. The segment registered sales of US$2.23 bn in 2013 and comprises stereo microscopes, fluorescence microscopes, near field scanning microscopes, inverted microscopes, phase contrast microscopes, and confocal scanning microscopes.

In 2013, electron microscopes stood as the second-largest product segment. Transmission and scanning electron microscopes are the sub-segments of electron microscopes. Scanning probe microscopes comprise atomic force microscopes and scanning tunneling microscopes.

On the basis of application, life sciences, material sciences, nanotechnology, semiconductors, and others are the segments of the microscopy devices market. Of all, in 2013, it was the life sciences segment that enjoyed a clear dominance and is expected to rise at a CAGR of 6.4% from 2014 to 2020. It is the semiconductors segment that held the second-largest share in the global market in the same year. Nevertheless, nanotechnology will display the fastest growth at a robust CAGR of 12.4% for the 2014-2020 period.

In terms of geography, North America, Asia Pacific, Europe, and Rest of the World are segments of the market. With a share of 40.9% in the overall market, Asia Pacific stood as the leader in the microscopy devices market in 2013. In several countries of this region, government-backed research and development programs that are carried out for the betterment of healthcare and industrial growth are reasons for this. As per the World Bank, presently, China is the second-largest investor in R&D programs.

Browse Full Global Microscopy Devices Market Report With Complete TOC @ http://www.transparencymarketresearch.com/microscopy-market.html

Hemoglobin A1c Testing Devices Market in the next decade

Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient’s blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test. Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions.

Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott’s ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes.

Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster paceduring the forecast period.

Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing.

Geographically, the global hemoglobin A1c testing devices market is categorized into four regions, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the market leader in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of automated processes is rapid in this region which results in high demand for advanced laboratory and point-of-care testing devices with new technologies. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR than others, owing to the presence of unmet healthcare needs, large diabetic population and increase in healthcare expenditure. Moreover, rising diabetes awareness among the general population will generate demand for diagnostic devices for HbA1c testing. Also, inadequate accessibility to the clinical laboratories in this region, demands more of point-of-care devices to enable immediate results during the patient visit.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1620

The global hemoglobin A1c testing devices market is characterized by the presence of some of the major companies including Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. These players are seeking to develop HbA1c analyzers with quicker turnaround time, higher accuracy and reliable results. Moreover, approval of devices for diagnosis of diabetes has reinforced the development activities of these organizations to introduce products for rapid and early diagnosis.

Major Trends in the Wearable Medical Devices Industry

The rising demand for remote monitoring, especially for chronically ill patients has pushed the growth of the global wearable medical devices market. Technological advancements and increasing awareness about the importance of monitoring the vital body statistics have further augmented the market’s growth. The global wearable medical devices market is estimated to expand at a CAGR of 16.4% during the period between 2013 and 2019. The overall market was worth US$2.0 bn in 2012 and is projected to reach a valuation of US$5.80 bn by 2019.

High Cost of Wearable Medical Devices to Restrain Growth of Global Wearable Medical Devices Market

The growing prevalence of diabetes has fuelled the need to monitor blood glucose level as well as other vital signs among patients. This has boosted the demand for wearable medical devices. The ease of use and interpretation of wearable medical devices, increasing per capita income, and the rise in adoption of wearable medical devices are some of the key factors propelling the growth of the global wearable medical devices market. However, the high cost of these devices will restrain the growth of the market, especially across the emerging economies. The overall market has a huge opportunity to grow with the increasing diabetic population in Asia Pacific.

Demand for Activity Monitors to Surge in Coming Years

On the basis of product type, the global wearable medical devices market has been broadly divided into wearable diagnostic medical devices and wearable therapeutic medical devices. Wearable diagnostic medical devices have been further categorized into fetal and obstetric devices, vital signs monitor, and neuromonitoring devices. The wearable therapeutic medical devices segment has been further divided into glucose/insulin monitoring, pain management, and respiratory therapy devices. In 2012, heart rate monitors dominated the overall wearable medical devices market. Heart rate monitors were the first wearable medical devices to be made available commercially. In the near future, the demand for activity monitors is expected to surge significantly.

On the basis of application, the global wearable medical devices market is segmented into remote patient monitoring, sports and fitness, and home healthcare. While the demand from the home healthcare application segment is rising due to the growing number of chronically ill patients, the overall market is expected to be propelled by the increasing usage of wearable medical devices in sports and fitness.

Get Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1733

Growing Demand from Asia Pacific to Drive Global Wearable Medical Devices Market

The global wearable medical devices market can be segmented into four key regions: Europe, North America, Asia Pacific, and Rest of the World. In 2012, North America dominated the overall market with 44% share. The region’s dominance in the market can be attributed to the growing demand for wearable heart rate monitors, coupled with rapid technological advancements. However, in the coming years, Asia Pacific is anticipated to register the fastest growth in the market owing to the growing demand for wearable medical devices across emerging economies such as India and China. The region is projected to expand at a CAGR of over 18% during the period between 2013 and 2019. However, the market is yet to tap the full potential of research and development activities across the region.

Key Players in Global Wearable Medical Devices Market

Some of the key players in the global wearable medical devices market are Corventis Inc., Basis Science Inc., Everist Genomics Inc., Draeger, Intelesens Ltd., Fitbit Inc., Nuubo, LifeWatch AG, Philips Electronics, Omron Corporation, Sotera Wireless, Polar Electro, Zephyr Technology Corporation, and Withings.

Dental Consumables Market Segment Forecasts up to 2023, Research Reports- TransparencyMarketResearch

Transparency Market Research has published a new market report titled, “Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.” According to the report, the global dental consumables market was valued at US$ 16,492.2 Mn in 2014 and is projected to expand at a CAGR of 5.7% from 2015 to 2023 to reach US$ 27,589.6 Mn in 2023.

The rise in global dental tourism induced by low labor costs, low fixed infrastructure costs and minimum government intervention in emerging economies such as India, Hungary and Turkey, has led to the rise in demand for dental consumable products in these nations. The major growth driver for the dental consumables market in developed countries such as the U.S., Australia, the U.K. and Germany; includes introduction of government initiated dental reforms such as The Comprehensive Dental Reform Act, 2012 along with other growth attributors such as global aging population and rise in demand for cosmetic dentistry.

Crown and bridges market is estimated to be the largest and fastest growing segment during the forecast period. Within the dental crowns and bridges segment, the ceramic fused to metal sub-segment held major share in terms of revenue, yet the pure ceramic implant is likely to surpass the ceramic fused to metal market by 2023. Dental implants reported to be the second leading segment is assessed to be an emerging trend among people with missing teeth due to accidents, disease, and injuries. Dental implants are mostly made of titanium and zirconium. Over the relatively short history of dental implants, titanium was determined to be the choice material for implant designs. Titanium, when installed correctly, could withstand the workload of the human jaw similarly to the natural tooth.

Similarly, dental biomaterials market is studied and estimated based on tissue regenerative, dental bone graft and membranes which are used to recover damaged and fractured teeth.

The orthodontics segment which includes anchorage appliances, ligatures, brackets and archwire is expected to grow at the second highest growth rate in the global dental consumables market. Endodontic products which deals with diagnosis and treatment of impairments related to tooth root, dental pulp and surrounding tissues studies are based on endodontic files, obturation products and endodontic sealers. The endodontic products are widely used in root canal treatment which is regarded to be one of the most common dental procedures performed across the globe. Despite repeated usage, low cost associated with the product components will lead to low market share during the forecast period of 2015-2023.

The periodontics segment include power driven scaling devices, dental sutures, locally applied therapeutic products, dental anesthetics and dental hemostats. Whereas, retail dental care essential products, one of the prime contributing segment is studied and estimated considering components such as dental brushes, whitening agent, specialized dental pastes, dental wash solutions and dental floss. Rising awareness regarding personal hygiene has resulted in the increased use of retail care products over the past few years. Most of these products are easily available in general retail stores and prescribed by mid-level practitioners. These factors combined with low marketing costs help in keeping the price of these products low and affordable to all. The market for others segment comprises face masks, distilled water, patient bibs, waste disposables and gloves.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=554

Rise in dental tourism in emerging market, aging trends and need for painless procedures, along with recent advancements in the dental implant techniques and number of procedures conducted average product consumption trend across the globe as well as country wise. All the above mentioned factors collectively drive the growth of the global dental consumables market.

The prominent companies profiled in this report includes 3M Health Care, Danaher Corporation, DENTSPLY International, Inc., Henry Schein, Inc., Institut Straumann AG, Ivoclar Vivadent AG, Nobel Biocare Holdings AG, Patterson Companies, Inc., Septodont, Ultradent Products, Inc. and Zimmer Biomet Holdings, Inc.

Leading Players in Sterilization Equipment and Disinfectants Market

Sterilization equipment and Disinfectants are used in healthcare facility to kill or eliminate harmful agents (such as bacteria, fungi and viruses) and are used as infection control agents. Increase in geriatric population coupled with rising number of surgeries in hospitals and clinics globally drive the growth of this market. According to the Centres for Disease Control and Prevention, approximately 46.5 million surgical procedures and 5 million gastrointestinal endoscopies are performed in the United States every year. Thus, with increasing number of surgeries the demand for sterilization equipment and disinfectants will also increase in order to avoid transmission of infection pathogens. The market of sterilization equipment and disinfectants is segmented as equipment, application and types of disinfectants. The sterilization equipment is further segmented as heat sterilization, low temperature sterilization, filtration sterilization and radiation sterilization. Application segment can be categorized as life sciences, medical devices and pharmaceuticals. While Low, intermediate and high level and oxidizing and non-oxidizing are the two segments of type of disinfectants. The global market for Sterilization Equipment and Disinfectant Market is expected to grow at a CAGR of 8.5% from 2013 to 2019 to reach an estimated value of USD 9,153.9 million in 2019.

Primary factors that drives the growth of the sterilization equipment and disinfectants market are geriatric population, rise in prevalence of cancer and increasing number of hospital-acquired infections (HAI). Furthermore, increase in per capita healthcare expenditure would also propel the growth of this market. In addition, technological advancements such as introduction of E-beam and gamma are expected to have a strong growth during the study period due to high product compatibility and low cost. However, high cost of sterilization equipment and disinfectant processes may restrain the growth of this market. In addition, safety is one of the concerns that restrict the growth of this market. For example, ethylene oxide is used as a sterilizing agent which also contains mutagenic as well as carcinogenic properties.

The market for heat sterilization equipment accounted for the largest share in terms of revenue of total sterilization equipment market in 2012 and is expected to grow at a CAGR of 8.6% during the forecast period. This growth is due to the fact that it is more user-friendly in comparison to low temperature sterilization and others. Also, it is safe while utilizing for sterilization. Low temperature sterilization is expected to grow at the highest CAGR of 10.9% during the forecast period 2013 to 2019. This growth is attributed to its efficiency in sterilizing complex and sophisticated medical devices such as endoscopes (via EtO sterilization).

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=389

Geographically, North America accounted for the largest share of the global sterilization equipment and disinfectant market, accounting for more than 40% of the total market in 2012. This is justified by increasing demand of non-disposable surgical instruments such as endoscopy devices, distractors and forceps. In addition, rapidly rising hospital acquired infections in North America further boost the growth of sterilization equipment and disinfectant market. Asia-Pacific region is the fastest growing market, growing at the CAGR of 10.9% during the year of 2013 -2019. Increasing prevalence rates of infectious diseases such as chikungunya, dengue and Japanese encephalitis due to population growth triggers the sterilization equipment and disinfectants market in these regions. The major players operating in the global sterilization equipment and disinfectant market include STERIS Corporation, Getinge Group and Advanced Sterilization Products Services Inc., Synergy Health Plc., Belimed A.G. and 3M Company.

Medical Equipment Rental Market To See Good Times Ahead

Transparency Market Research, a global market intelligence firm, has recently announced the publication of a new market research report made available on the company website. The research study, titled “Medical Equipment Rental Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” talks about the global medical equipment rental market, presenting an overview of the market, along with the drivers and barriers that will determine the growth of the market throughout the forecast period.

According to the research report, in 2013, the global market for medical equipment rental was valued at US$33.4 bn and is estimated to reach a value of US$49.1 bn by the end of 2020. The market is projected to register a 5.80% CAGR between 2014 and 2020.

The rising pressure to reduce expenses in hospitals, the growing incidence of chronic diseases, increasing geriatric population, and safety against obsolescence of technologies are some of the major factors that are expected to boost the demand for medical equipment rental throughout the forecast period. Moreover, the expansion of the distribution network in developing countries is further expected to fuel the growth of the market. However, the poor pricing flexibility and absence of appropriate regulatory policies are projected to hamper the growth of the global medical equipment rental market in the near future.

The global medical equipment rental market has been classified on the basis of device category into surgical equipment, electronic/digital equipment, personal/home care equipment, durable medical equipment, and storage and transport. In 2013, the durable medical equipment segment held a 40% share of the global medical equipment rental market. This segment is projected to remain in its leading position in the forecast period, exhibiting a 5% CAGR between 2014 and 2020.

Furthermore, the global medical equipment rental market has been categorized on the basis of end use into medical equipment rental, personal/home care, and institutional medical equipment rental. In 2013, the chronic and geriatric patient sub-category of personal/home care held a 50% share of the overall personal/home care segment.

On the basis of geography, the global medical equipment rental market has been divided into Asia Pacific, Europe, North America, and Rest of the World. In 2013, Europe led the global market, accounting for a 30% share in the overall medical equipment rental market, followed by the North America medical equipment rental market. The North America market is estimated to surpass Europe in the next few years. On the other hand, the Asia Pacific market for medical equipment rental is anticipated to register the highest growth rate – a 6% CAGR between 2014 and 2020.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2543

Furthermore, the research study covers the competitive landscape of the global medical equipment rental market, including detailed profiles of the major players operating in the market. As per the study, the global medical equipment rental market is extremely fragmented, owing to the dominance of a few large players such as Siemens Financial Services, Apria Healthcare Group, Stryker Corporation, and Hill-Rom Holdings, Inc.

Some of the other players in the market are Universal Hospital Services, Inc., Port Huron Hospital Medical Equipment, Hill-Rom Holdings, Centric Health Corporation, Westside Medical Supply, Woodley Equipment Company Ltd., US Med-Equip, Nunn’s Home Medical Equipment, and Walgreen Co.

Growing Trends in Nonalcoholic Steatohepatitis Market

A new market research report by Transparency Market Research, titled “Nonalcoholic Steatohepatitis (NASH) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023,” helps in the analysis of key trends prevalent in the market for nonalcoholic steatohepatitis. The study also comprises a review of the chief factors inhibiting and fuelling the growth of the market, thus helping stakeholders in gaining an in-depth understanding of the nonalcoholic steatohepatitis market.

The study also includes data gained through the Porter’s five forces model and thus helps in gaining insights into the key threats posed by the emerging entrants as well as the bargaining powers of both buyers and suppliers. Moving further, the study also includes the major strategies adopted by the prime players dominant in the market, along with detailing the key mergers and acquisitions, product launches, and agreements and collaborations seen in the market. In addition, the study also entails SWOT analysis as well as distinctive graphics on the major market segments.

As per the report, nonalcoholic steatohepatitis (NASH) is a kind of non-alcoholic fatty liver disease (NAFLD) involving a hepatocyte injury seen in the form of fibrosis, hepatic steatosis, and inflammation. The report states that the prime driver fuelling the growth of the market is the rising occurrence of NAFLD cases and their transformation to NASH. In addition, the shifting lifestyle patterns and increasing obesity are also stimulating the growth of the market. However, as mentioned in the report, the nonalcoholic steatohepatitis market is presently in its nascent stage owing to the fact that there is an absence of FDA-approved drugs for the treatment of NASH till date. This will have a negative impact on the growth of the market. Nevertheless, there are numerous pipeline drugs in phase II and phase III of clinical trials, including Aramchol and Elafibranor and these can emerge as potential drugs within the market for the treatment of NASH.

The report states that this disease is comparatively less prominent as compared to other disorders of the liver. The progression of NASH takes place over a period of time as a subtle and gradual process. In addition, NASH may either recede or halt without the requirement for any treatment owing to the liver’s regenerative property. This may also act as a key barrier for the growth of the market for nonalcoholic steatohepatitis, as per this report.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7691

According to the report, the chief players operating in the market for nonalcoholic steatohepatitis are Echosense SA, Exalenz Bioscience Inc., AstraZeneca plc, Galmed Pharmaceuticals Ltd., GENFIT Corp, Intercept Pharmaceuticals, Inc., Galectin Therapeutics Inc., One Way Liver Genomics, Perspectum Diagnostics, S.L, Matinas Biopharma Holdings, Inc., and Vital Therapies, Inc., among others.

Teleradiology Market Responds to Impressive Progress in Medicine and Healthcare

Transparency Market Research has published a new report on the global teleradiology market. As per the report, the global teleradiology market is predicted to expand at a 22.30% CAGR during the period between 2013 and 2019. The report, titled ‘Teleradiology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019,’ states that the global teleradiology market stood at US$0.9 bn in 2012 and is expected to reach US$3.8 bn by 2019 owing to factors such as technological advancements and the introduction of mhealth services.

Teleradiology consists of the electronic transmission of radiological images from a particular location to another in a digital format using the internet. Image transfer is primarily carried out from the sender’s end to a secondary location for either consultation or an official diagnosis. Consistent developments and advancements in digital imaging technology have favored the acceptance of teleradiology technologies. The increasing acceptance of social media platforms and the internet in general is further expected to augment the use of teleradiology practices across the globe.

Continuous upgradation of radiology information systems (RIS) and picture archiving and communication systems (PACS) is expected to enhance the teleradiology process. The global teleradiology market is segmented on the basis of geography and modality. Based on modality, the global teleradiology market is classified into x-ray, ultrasound, computed tomography (CT), nuclear imaging, and magnetic resonance imaging (MRI). The x-ray teleradiology segment is expected to register new growth opportunities due to increased awareness, low costs compared to other modalities, and increasing digitalization.

Ultrasound imaging technology, popularly used in diagnosing women’s ailments, is majorly employed to track and visualize development stages of a fetus at the time of pregnancy. Compared with x-rays, ultrasound imaging technology is more beneficial due to its minimally invasive nature. The acceptance of MRI imaging technology is still at a nascent stage due to the high costs of the equipment and lack of technical expertise.

Based on geography, the global teleradiology market is divided into Europe, Asia Pacific, North America, and Rest of the World. In 2012, the global teleradiology market was led by North America, which held a revenue share of more than 33%. The presence of well-equipped healthcare institutions and hospitals and the increasing use of high-bandwidth internet are predicted to propel the North America teleradiology market in the years to come.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1132

The Asia Pacific teleradiology market is expected to register considerable growth in the coming few years due to ongoing developments in healthcare informatics and medical imaging platforms. However, lack of image data security is expected to hamper the growth of the global teleradiology market through the forecast period.

Agfa-Gevaert N.V., American TeleCare, Inc., Cybernet Systems Corporation, ONRAD, Inc., Radisphere National Radiology Group, Inc., Sectra AB, StatRad, Teleradiology Solutions, and Virtual Radiologic (vRad) are some of the leading companies in the global teleradiology market. The entry of new companies is expected to make the global teleradiology market highly competitive in the coming years.

Wound Care Market Witnesses Rising Demand and Investment from R&D Activities

Transparency Market Research presents a new market study on the global wound care market for the 2014-2020 period. The report, titled “Wound Care Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast 2014 – 2020,” studies the global wound care market as a whole with a focus on the China market for the same. The report covers vital market indicators such as growth drivers, growth restraints, consumer trends, product portfolio, and size projections of this market for the forecast period.

Using validated analytical tools such as Porter’s five forces analysis, the report anticipates the future outlook of the global as well as China market. The bargaining power of suppliers and buyers, degree of competition in the future, threat from alternative products, and threat from new entrants are examined via the Porter’s five forces model. In the company profile section of the report, insights into the leading players in the wound care market are provided with respect to pipeline products, new initiatives, financial status, breakthroughs, mergers and acquisitions, etc.

The wound care market is progressing expeditiously, says the report. This is because product manufacturers are consistently introducing innovative products for healing of injuries and to prevent infections in wounds and abrasions. These initiatives are also supported by government initiatives in the form of expert guidance for innovative products and funding of projects partially. In addition, the rising incidence of hospital-acquired infections, advances in chemical and biological sciences, and the use of innovative materials for wound care products are favoring the market’s growth.

On the contrary, the growth of this market is impeded due to certain factors. The high cost of design and manufacture of advanced wound care products and the increasing degree of competition are conspicuous impediments to this market. With the presence of new entrants in the global and China market for wound care, existing market participants need to develop cutting-edge products to survive the competition in this market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=106

The global wound care market is categorized on the basis of product type and geography. The product type segments of the market are basic, bioactive, therapy, advanced, and traditional. The components of the advanced wound care market are moist wound care, foam wound care, hydrogels, alginates, and hydrocolloid. Amongst all, the bioactive product segment will display the highest growth rate in the global and China market during the forecast period.

Region-wise, North America, Europe, Asia Pacific, and Rest of the World are the segments of the global wound care market. Whilst, currently, North America is the clear leader in the global wound care market, Asia Pacific will register the highest growth rate in this market in the coming years.

Top companies operating in the global wound care market mentioned in this report are Baxter International Inc., Smith & Nephew, Coloplast AS, Hollister Inc., Covidien PLC, 3M Company, Derma Sciences Inc., and others.

Global Demand for Acute Care Needleless Connectors Market

Conventional needle based I.V. catheters, administration sets, and syringes are used for intravenous administration of fluids. However, use of needle based IV systems give rise to needlestick injuries to healthcare workers leading increased incidences of blood borne infections. Therefore, needleless connectors were introduced in 1980s to enhance the safety of healthcare workers. As a result, rate of needlestick injuries decreased significantly in later years. However, eventually it was observed that the use of needleless connectors lead to augment the risk of catheter related blood stream infections. Thus, various designs and mechanisms are introduced to resolve the problems associated with needleless connectors and catheter related blood stream infections. Needleless connectors provide convenience to the nursing staff in administering medication and drawing blood from the attached catheter, thus, these products are widely used in healthcare settings such as acute care hospitals where intravenous administration of medication and blood withdrawal is necessary during the course of treatment offered.

The global acute care needleless connectors market has been segmented based on the type of mechanism. Positive fluid displacement connectors segment accounted for the largest market share of around 34% in 2013. Dominance of this segment was mainly attributed to low cost of the commercially available positive fluid displacement needleless connectors. However, suspected link of positive fluid displacement connectors with increased rate of catheter related blood stream infection is anticipated to limit the growth of this market during the forecast period from 2014 to 2020.

The commercially available needleless connectors are majorly of two types, simple and complex. Simple needleless connectors are less expensive as they have fewer parts compared to complex needleless connectors. In addition, simple connectors do not have internal moving parts thus offering straight fluid pathway. Whereas, complex connectors have internal mechanical valves that leads to non-straight fluid pathway. Complex needleless connectors market was dominant in terms of revenue in 2013 majorly due to higher cost of these devices and large availability of products with mechanical valves in the market. However, increasing incidences of catheter-related bloodstream infections (CRBSI) and catheter lumen occlusion due to the use of complex needleless connectors, the demand for simple needleless connectors is likely to grow rapidly during the forecast period between 2014 and 2020.

Based on dwell time, the global acute care needleless connectors market has been segmented into 7 days connectors and other than 7 days connectors. The other than 7 day needleless connectors segment is anticipated to grow at the highest CAGR during the forecast period. Since, these connectors are available at a cheaper rate and offer added credibility of reduced risk of CRBSI infection rate than the 7 day needleless connectors.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4230

Geographically, North America is leading the global acute care needleless connectors market. High awareness among healthcare practitioners, improved healthcare infrastructure and rapid growth in aging population are the major factors driving the market in North America. Furthermore, Asia Pacific is anticipated to show significant growth in the forecast period owing to increasing prevalence of chronic diseases, growing number of hospitals and healthcare facilities, and geographical expansion of market players in India, China, Southeast Asia, and Australia. Key players mapped in the report include, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, CareFusion Corporation, ICU Medical Inc., Nexus Medical LLC, RyMed Technologies LLC, and Vygon SA.

Expansion of Regional Markets to Drive the Asia Pacific Acute Care Needleless Connectors Market

Geographically, the global acute care needleless connectors market is segmented into Asia Pacific, North America, Europe, and Rest of the World. The global acute care needleless connectors market is dominated by North America owing to factors such as a rapidly growing geriatric population in this region, high quality healthcare infrastructure, and widespread awareness amongst healthcare professionals.

It is however, the Asia Pacific market that will expand substantially in the forthcoming years. Factors that propel the Asia Pacific acute care needleless connectors market are growing number of healthcare facilities and hospitals, high incidence of chronic ailments, and most importantly expansion of regional markets such as Australia, Southeast Asia, China, and India.

The prominent companies operating in the global acute care needleless connectors market are Vygon SA, RyMed Technologies LLC, Nexus Medical LLC, ICU Medical Inc., CareFusion Corporation, Becton Dickinson and Company, B. Braun Melsungen AG, and Baxter International Inc. High incidence of cases of catheter related blood stream infections hampers the growth of the global acute care needleless connectors market. Steep cost of branded products as against the domestic substitutes and local products is another factor restraining the market. High investments in a few of the emerging economies is likely to create lucrative growth opportunities in the global acute care needleless connectors market.

Global Demand for Nuclear Medicine Market

Nuclear medicine is redefining the paradigms of medical imaging by providing detailed and accurate results as well as early detection of potentially fatal conditions. This has brought more consumers in the folds of the global nuclear medicine market, leading to the market growing at a steady rate in the coming years, says a study by Transparency Market Research. According to the report, titled ‘Nuclear Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023.’

Nuclear medicine entails the use of small amounts of radioactive isotopes. Diagnoses are conducted using different kinds of radiological scanning techniques such as computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), and magnetic resonance imaging (MRI).

The use of nuclear medicine is increasingly seen in the diagnosis and treatment of neurological disorders, cardiovascular disease, cancers, and other disorders and abnormalities within the body. With a growing demand for accurate diagnosis and treatment, technologically sophisticated healthcare solutions are much in demand. This augurs well for the growth of the global nuclear medicine market. The TMR report also states that new advancements in neurological applications will aid the growth of the global nuclear medicine market.

According to the report, strict regulatory guidelines governing the use of nuclear medicine will create obstacles in the path of the market’s growth. At the same time, the use of traditional diagnostic procedures still continues to give competition to nuclear medicine, which could restrain the market, too. The world over, there is still a dearth of highly trained and experienced professionals in the field of nuclear medicine. A shortage of radioactive isotopes could also potentially impede the growth of the nuclear medicine market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4672

The report segments the global nuclear medicine market on the basis of application and geography. Nuclear medicine is primarily used in diagnostic and therapeutic applications, which form the two application segments of the nuclear medicine market.

The diagnostic applications segment is further divided into: neurology, nephrology, cardiovascular, pulmonology, oncology, and hepatology. The use of nuclear medicines is seen most widely in cancer treatment and scar tissue removal.

From the geographical standpoint, the global market for nuclear medicine is segmented into the following markets: Asia Pacific, North America, Europe, the Middle East and Africa, and Rest of the World. Although North America was the most dominant market for nuclear medicine in the world in 2015, the fastest growth rate can be expected from Asia Pacific. Countries in the region are beginning to see an upswing in the incidence of cancer and cardiovascular diseases.

The report includes a thorough evaluation of the performance and standing of leading companies in the nuclear medicine market. These include: G.E Healthcare, Ashby Gorman Baker Ltd., Pinestar Technology, Inc., and Mediso Ltd.

Emerging Opportunities in Knee Implants Market

Knee implant procedures are done when a patient has knee pain, a traumatic injury or a disability from rheumatoid arthritis, or osteoarthritis. In the surgical process, a surgeon implants the device (artificial device) and replaces the damaged knee with it. There are many different types of implants - which are made of metal alloys, strong plastic parts or ceramic material.

The knee implants market will grow due to factors such as increase in the rate of age related diseases like osteoporosis and arthritis, diabetes, obesity, ageing population and injuries related to sports. However due to technological advances such as minimal invasive surgery, better implant materials and better success rates, even the younger population are able to undergo knee replacement surgery.

Technological advancements in knee implants such as minimally invasive surgery have made it possible to have procedures with small incisions, lower blood loss, lesser tissue injuries and faster recovery time. Growing awareness among patients regarding their health will also help to drive the market.

The knee implants market has had to face some challenges due to the economic slowdown. This has resulted in many hospitals cutting down their costs to increase their market share. Many patients are reluctant to go in for knee implantation procedures due to the high cost involved. Further, the knee implant market is also showing pressure due to the intense competition among manufacturers on the prices.

Presently, in this emerging market, both patients and surgeons have more options for implant due to the newer available techniques which are giving better outcomes for patients. This has given options for implant manufacturers companies to provide new product solutions.

The global knee implants market was USD 8.4 billion in 2011 and it is forecasted that this market will reach USD 15 billion in 2018 with compound annual growth rate of 8.64% during 2011 to 2018. The U.S. and Europe are the two big markets for knee implants and both the countries enjoy more than 70% market share of global knee implants.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=513

The leading players in the knee implants market are B.Braun, Smith and Nephew, Stryker, Zimmer, and Depuy. They accounted for almost 80% of the total market. Zimmer is the market leader among them with 30% market share. The medical device manufacturing companies are increasing their market share with marketing campaigns and awareness.

This market research report analyzes important market segments, and major geographies. This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

mHealth Monitoring And Diagnostic Medical Devices Market witnesses a year of significant changes

Transparency Market Research recently announced the publication of a new market research report, titled “mHealth Monitoring And Diagnostic Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019,” which provides a comprehensive market overview, including the market drivers and barriers, product segmentation, current market trends, geographical segmentation, and competitive landscape of the market.According to the research study, in 2012, the global mHealth monitoring and diagnostic medical devices market for was valued at US$0.6 bn and is estimated to reach a value of US$8 bn by the end of 2019, exhibiting an enormous 43.30% CAGR between 2013 and 2019.

mHealth monitoring and diagnostic medical devices are used to deliver healthcare facilities with the help of communication devices, including tablet computers, mobile phones, and PDAs. The global market for mHealth monitoring and diagnostic medical devices is an emerging market and the demand has been growing at a fast pace due to the rising prevalence of chronic diseases.

The global market for mHealth monitoring and diagnostic medical devices has been segmented on the basis of product type into sleep apnea monitors, blood pressure monitors, multi-parameter monitors, pulse oximeters, cardiac monitors, glucose monitors, and others. Among these, the glucose monitors segment is projected to exhibit an explosive 49.40% CAGR between 2013 and 2019. The increasing incidence of diabetes across the globe, along with the increasing demand for minimally invasive glucose monitoring devices, is estimated to fuel the growth of the glucose monitors segment in the next few years.

Moreover, the tremendous rise in the number of smartphones and innovations in mHealth devices due to technological advancements are other factors that are driving the overall market. Furthermore, the multi-parameter monitors segment is anticipated to witness rapid growth owing to rising awareness regarding healthy lifestyles and fitness in several developed economies.

The global market for mHealth monitoring and diagnostic medical devices has been divided on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Currently, the North America market accounts for the largest share in the overall market, thanks to the presence of several manufacturers in the region, the growing population owning a smart consumer electronic device such as tablets or smartphones, technological developments, and rising awareness regarding new technology and devices.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2018

On the other hand, the Asia Pacific market for mHealth monitoring and diagnostic medical devices is considered as one of the most favorable markets throughout the forecast period. This region is estimated to register a high growth rate, owing to the increasing geriatric population, growing prevalence of chronic diseases, rising awareness regarding the benefits of diagnostic devices, and increasing demand for home care monitoring devices. In addition, the growing use of smartphones in several countries such as Singapore, India, China, Australia, New Zealand, and Japan is further driving the global market for mHealth monitoring and diagnostic medical devices.

Furthermore, the study talks about the competitive landscape of the market, including detailed profiles of the major players. Some of the prominent players operating in the global market for mHealth monitoring and diagnostic medical devices are BioTelemetry Inc., F. Hoffmann La-Roche Ltd., AT&T, Inc., Johnson & Johnson, DexCom, Inc., Bayer HealthCare AG, Medtronic Inc., Boston Scientific Corporation, Masimo Corporation, Omron Healthcare, LifeWatch AG, and Dräger AG.

Hospital Acquired Disease Testing Market Dynamics and Opportunities Report by Transparency Market Research

Transparency Market Research has published a research report that discusses the trends and dynamics in the global hospital acquired disease testing market. The research report, titled “Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” includes thorough research on the market collated by industry experts.

The research report includes an evaluation of the diagnostic tests performed to diagnose hospital-related infections. Also known as nosocomial infections, hospital acquired diseases have become a growing cause of morbidity across the world. The research report has used SWOT analysis to identify the strengths, weaknesses, opportunities, and threats of the market. Furthermore, it also includes Porter’s five forces analysis that highlights the threat of new entrants, the threat of substitute products or services, the bargaining power of customers (buyers), the bargaining power of suppliers, and the intensity of competitive rivalry.

According to the research report, the global hospital acquired disease testing market was valued at US$0.4 bn in 2014 and is likely to reach US$2.0 bn by 2023, rising at a CAGR of 19.9% from 2015 to 2023. This growth will be attributable to the growing number of cases of nosocomial infections.

In the past few years, the high incidence of nosocomial infections has led to a high rate of morbidity. This is especially seen amongst patients who have a weaker immune system and fall prey to poor hygiene conditions in the hospitals. The growing pool of geriatrics is the primary reasons for the growth in the prevalence of hospital acquired diseases across the globe.

The global hospital acquired disease testing market has been segmented on the basis of test and geography. On the basis of test, this market is segmented into urinary tract infections, pneumonia infections, bloodstream-associated infections, MRSA infections, surgical site infections, and others. Geographically, this market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa.

Of all the segments based on test type, the hospital acquired urinary tract infection diagnostics segment holds a dominating share in the overall market due to the high prevalence of urinary infections and its impact on morbidity. Analysts predict that this segment will continue to show its dominance in the market through 2023. Additionally, the market for testing solutions such as surgical site infections and pneumonia (ventilator associated and hospital associated infections) will also expand due to the high prevalence of these conditions in emerging economies in Latin America, Asia Pacific, and other developing regions.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759

Some of the top players mentioned in the research report about the global hospital acquired disease testing market are Diatherix Laboratories Inc., Qiagen GmbH, Gen-Probe Inc., L Hoffman La Roche, Cepheid, Inc., Meridian Biosciences, Life Technologies Corporation, Nordion, Inc., and Cantel Medical Corporation. The research report also offers a detailed explanation of the competitive landscape of the global hospital acquired disease testing market. Furthermore, it also assesses the financial overview, research and development activities, business and marketing strategies, product portfolio, and strategic mergers and acquisitions of these top players in the overall market.

A brief review of Anti-Adhesion Products Market

Adhesion is one of the common problems affecting almost 55% to 90% patients followed by surgery. Adhesion is a band of scar tissue formed between organs and tissue after a surgery as a part of a normal healing process. However, when it connects wrong tissues into each other, adhesions may lead to severe clinical symptoms such as pelvic pain, intestinal blockage, infertility and loss of sensation depending on the location and size of the adhesions. Adhesions are most common after surgeries such as abdominal surgery, thoracic surgery, gynaecological surgery and plastic surgery. After abdominal surgery, bowels and pelvic organs may adhere with each other as a result of adhesion causing risks for small bowel obstruction and severe pain. The various types of adhesions based on their locations are abdominal adhesions, intestinal adhesions, intraperitoneal adhesions and pelvic adhesions.

Some of the anti-adhesion products available in the market are Adept (Baxter), Seprafilm (Genzyme), INTERSEED (Johnson & Johnson) and Surgiwrap (MAST Biosurgery). The market for anti-adhesion products can be segmented on the basis of types of surgery such as abdominal surgery, gynecological surgery and other surgical procedures. The market for anti-adhesion products is growing due to large number incidences of adhesion associated with various surgeries. Usually 55% to 90% patients undergoing abdominal and gynecological surgeries face adhesion problems. Presently, North America represents the largest market as a number of products have been approved by FDA. Asia-Pacific is experiencing growth as large number of patients are undergoing abdominal and gynecological surgeries. In the coming future the market will witness growth with the introduction of new products with more efficacy.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1506

Some of the major vendors operating in this market are Johnson & Johnson, Baxter International, WL Gore, Anika Therapeutics, Inc., Angiotech Pharmaceuticals, Inc., Genzyme Corporation, LifeCell Corporation and MAST Biosurgery AG.

Blood Pressure Monitoring Testing Market Witnesses Rising Demand and Investment from R&D Activities

The global blood pressure monitoring testing market was recorded at US$1.7 bn in 2012. It is exhibiting a CAGR of 11.50% within a forecast period of 2013 and 2019, by the end of which this market will reach US$3.6 bn. This data is provided through a research report by Transparency Market Research, titled “Blood Pressure Monitoring Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.” The report incorporates all values essential in gauging the driving and restraining factors concerned with this market and provides a logical forecast for the same.

According to the report, the global blood pressure monitoring testing market is being driven by the increasing number of patients being diagnosed with high blood pressure. The reasons for high blood pressure include the increasing levels of stress faced on a daily basis, the reducing amount of physical activity performed by individuals, and the rising percentage of the geriatric demographic.

Nearly 7 mn people in the U.S. die from hypertension-related diseases each year. In 2012, about 76 mn U.S. citizens were suffering from high blood pressure. This illustrates the importance of hypertension in terms of being a global health threat.

Medical research and diagnostic numbers have shown that people above the age of 50 have a 90% chance of developing hypertension. Some of the most common causes of high blood pressure are social, metabolic, and behavioral. Other causes include consumption of toxins including alcohol and tobacco. All these reasons are contributing to a large number of people suffering from blood pressure issues, creating a high demand from the global blood pressure monitoring testing market.

The report provides a segmented analysis of the global blood pressure monitoring testing market in terms of types and geography.

According to type, the segments of the global blood pressure monitoring testing market are blood pressure instrument accessories, blood pressure transducers, ambulatory blood pressure monitors, automated blood pressure monitors, and sphygmomanometers. The market is expected to be shaped by the growing adoption of digital sphygmomanometers, which is currently higher than the demand for mercury-based and aneroid variants. The digital ones are a lot simpler to use and can give a more accurate reading than conventional sphygmomanometers.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1630

An increasing number of people continue to suffer from blood pressure issues, owing to factors such as chronic disorders, diabetes, obesity, and congenital heart diseases. Regardless of the manner of incurring hypertension, the global blood pressure monitoring testing market and its segment of sphygmomanometers will continue to grow in value.

The report’s analysis of the global blood pressure monitoring testing market on the basis of geography involves the segmentation of the market into the four major regions of North America, Europe, Asia Pacific, and the Rest of the World. As per the report, North America dominated the global blood pressure monitoring testing market in 2012. Hypertension was one of the most common reasons for cardiovascular diseases in North America, creating high demand from this market.

Key players in the global blood pressure monitoring testing market are Welch Allyn, Spacelabs Healthcare, Philips Healthcare, Omron Healthcare, Inc., Nihon Kohden Corporation, Suntech Medical, Inc., Masimo Corporation, GE Healthcare, Covidien PLC, and A&D Medical, Inc.

Advanced Remote Patient Monitoring Systems Market Segment Forecast up to 2020

Remote patient monitoring systems refer to a technology that enable monitoring of patients outside the conventional clinic or hospital premises. The main concept behind remote patient monitoring is to avoid the inconvenience caused to critical patients. Advanced remote patient monitoring systems include sophisticated peripherals that facilitate real time audio and video service. This enables face to face interaction between the patients and medicine professionals. These systems are highly useful as it reduces the travel time of patients to clinics and improves the medical consultation. This can reduce mortality rates and enable efficient use of medical resources. The connectivity between the patients and medical professionals is attained using wireless technologies such as wireless local area networks (WLAN) and cellular networks. Advanced remote patient monitoring systems helps in avoiding emergency overcrowding, manage large number of patients and improved maintenance of electronic health records (EHR).

One of the major factors driving the advanced remote patient monitoring systems market is low treatment costs. Advanced remote patient monitoring systems reduce the expenses such as hospital admissions, travelling costs and others. Increasing number of patients with diseases such as diabetes, congestive heart diseases and others is major factor driving the demand for advanced and cost effective healthcare solutions. Monitoring systems deliver low cost, fast and reliable consulting of these diseases as compared to conventional consulting. Furthermore, advanced remote patient monitoring systems help the medical professional to monitor number of patients simultaneously from one place. This enables increased coverage of patient monitoring with less number of medical personnel.

With continuous monitoring of patients, the medical professionals can diagnose serious disorders in an early stage. This leads to improved patient care and reduced mortality rate. Furthermore, increasing adoption of mobile devices such as smartphones, tablet personal computers (PCs) and others is another factor boosting the advanced remote patient monitoring systems market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3444

The advanced remote patient monitoring systems market is segmented based on the type of monitoring, end-user and geographic regions. The different types of monitoring include vital signs monitoring, diagnostic monitoring and specialized monitoring. Vital sign monitoring comprises blood pressure, pulse oximeters and other physical parameters. Diagnostic monitoring includes electrocardiogram (ECG) and others. Specialized monitoring includes disease specific monitoring such as anesthesia, diabetes - glucose, cardiac rhythm, respiratory and other disorder monitoring. The advanced remote patient monitoring systems market is segmented based on end-users as hospital based patients and telemedicine patients. Geographically, the advanced remote patient monitoring systems market is segmented into four major regions as North America, Europe, Asia Pacific and Rest of the World (RoW). At present, North America accounts for the largest share in terms of revenue in advanced remote patient monitoring systems market. This is mainly due to rising lifestyle diseases such as atherosclerosis, asthma, osteoporosis and other heart diseases. Additionally, availability of sophisticated monitoring devices is another factor responsible for this growth. North America is expected to remain the dominant market for the next few years owing to high investment in healthcare sector.

Some of the leading players in advanced remote patient monitoring systems market include Abbott Laboratories, Drager Medical GmbH, Covidien Ltd., GE Healthcare, Masimo Corporation, Johnson and Johnson Inc., Mindray Medical International Ltd., Natus Medical Inc., Mortara Instrument Inc., Nihon Kohden Corporation, Omron Healthcare Co. Ltd., Nonin Medical Inc., Koninklijke Philips N.V., Roche Diagnostics Ltd. and others.